Published in J Thromb Haemost on June 01, 2011
The phenotypic legacy of admixture between modern humans and Neandertals. Science (2016) 2.20
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23
Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost (2013) 1.22
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol (2013) 1.12
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Common genetic risk factors for venous thrombosis in the Chinese population. Am J Hum Genet (2013) 1.01
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
A Comparison of Logistic Regression, Logic Regression, Classification Tree, and Random Forests to Identify Effective Gene-Gene and Gene-Environmental Interactions. Int J Appl Sci Technol (2012) 0.91
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol (2012) 0.85
Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C. PLoS One (2013) 0.84
Association of GATA4 sequence variation with alcohol dependence. Addict Biol (2012) 0.82
Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiol Genomics (2015) 0.80
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost (2016) 0.78
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res (2015) 0.77
Associations of prodynorphin sequence variation with alcohol dependence and related traits are phenotype-specific and sex-dependent. Sci Rep (2015) 0.76
A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease. Front Med (Lausanne) (2016) 0.76
Entropy based genetic association tests and gene-gene interaction tests. Stat Appl Genet Mol Biol (2011) 0.75
The association of copy number variation and percent mammographic density. BMC Res Notes (2015) 0.75
Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor. Circ Cardiovasc Genet (2017) 0.75
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism. Haematologica (2016) 0.75
Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. J Thromb Haemost (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet (2005) 25.34
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52
Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol (1985) 11.38
Penalized logistic regression for detecting gene interactions. Biostatistics (2007) 5.53
European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27
Attributable risk percent in case-control studies. Br J Prev Soc Med (1971) 5.21
Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med (2005) 3.59
Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA (2007) 3.50
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet (2006) 2.94
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol (2005) 2.85
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Gene variants associated with deep vein thrombosis. JAMA (2008) 2.74
Reporting and interpretation in genome-wide association studies. Int J Epidemiol (2008) 2.73
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64
Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am (2003) 2.47
ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost (2007) 2.38
Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet (2002) 2.26
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost (2005) 1.92
Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood (2009) 1.81
Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet (2000) 1.69
Coagulation and innate immune responses: can we view them separately? Blood (2009) 1.61
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost (2007) 1.59
Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res (2006) 1.48
Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood (2007) 1.48
Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol (2008) 1.47
SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study. Clin Chem (2009) 1.45
The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost (2005) 1.33
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood (2006) 1.24
Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost (2009) 1.24
Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem (2002) 1.18
Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem (1992) 1.15
P-selectin in haemostasis. Br J Haematol (2004) 1.14
Familial segregation of venous thromboembolism. J Thromb Haemost (2004) 1.08
ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost (2005) 1.08
Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology (2003) 1.07
Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost (2007) 1.04
Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost (2004) 1.03
The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis (2006) 1.02
Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand J Infect Dis (2003) 1.00
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect? Br J Haematol (2000) 0.98
Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost (2009) 0.91
Update on factor V Leiden association with venous thromboembolism in the LITE Study. Blood (2007) 0.89
High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol (2001) 0.85
Kininogens are antithrombotic proteins In vivo. Arterioscler Thromb Vasc Biol (1999) 0.85
Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation. J Thromb Haemost (2007) 0.81
Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost (2005) 0.81
P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study. J Thromb Haemost (2008) 0.81
Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis (2009) 0.80
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature (1991) 5.40
Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell (2000) 4.88
Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem (1992) 4.88
Biochemical evidence that patched is the Hedgehog receptor. Nature (1996) 4.53
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26
Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science (1997) 3.13
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell (1983) 3.00
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res (1996) 2.89
Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol (1993) 2.77
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell (1992) 2.67
Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55
The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A (1987) 2.51
The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet (1995) 2.30
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology (2001) 2.30
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood (1999) 2.14
Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex. Neuron (2000) 2.04
The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86
Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg (1994) 1.86
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J (1998) 1.83
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J Virol (1999) 1.75
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J Virol (1990) 1.65
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome. Bone Marrow Transplant (2001) 1.52
Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem (1993) 1.49
Neural basis of endogenous and exogenous spatial orienting. A functional MRI study. J Cogn Neurosci (1999) 1.42
In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol (1997) 1.41
Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc Natl Acad Sci U S A (2001) 1.37
Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci (2001) 1.37
Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol (1999) 1.33
Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry (1997) 1.33
Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J Biol Chem (1993) 1.32
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. J Biol Chem (1993) 1.32
Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. EMBO J (1995) 1.30
Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab (2000) 1.28
Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet (1997) 1.25
Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res (2001) 1.24
Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4. Mol Cell Biol (2000) 1.24
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23
The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology (2003) 1.22
HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res (2000) 1.20
Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J Virol (2001) 1.19
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer (2009) 1.19
Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg (1997) 1.15
Minus-strand DNA is present within murine type C ecotropic retroviruses prior to infection. J Virol (1993) 1.14
The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc (2000) 1.13
Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg (2001) 1.13
The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line. Proc Natl Acad Sci U S A (1997) 1.12
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet (2003) 1.10
Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes Dev (1997) 1.10
Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res (1998) 1.09
Familial segregation of venous thromboembolism. J Thromb Haemost (2004) 1.08
Alpha-synuclein, pesticides, and Parkinson disease: a case-control study. Neurology (2008) 1.07
Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem (1996) 1.05
Independent association of high blood pressure and aortic atherosclerosis: A population-based study. Circulation (2000) 1.05
The human cationic amino acid transporter (ATRC1): physical and genetic mapping to 13q12-q14. Genomics (1992) 1.04
Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression. Mol Cell Biol (1993) 1.04
Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit. Development (1997) 1.04
Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromuscul Disord (1999) 1.04
Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol (1996) 1.04
Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol (2001) 1.03
A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog (1992) 1.03
Functional MRI evidence for subcortical participation in conceptual reasoning skills. Neuroreport (1997) 1.01
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology (2001) 1.00
Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells. Biochem J (1991) 0.99
Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol (1987) 0.99
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. Int J Oncol (1999) 0.98
To bedlam and back. J Psychosoc Nurs Ment Health Serv (1986) 0.98
Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors. J Biol Chem (2000) 0.96
Novel pattern of P53 mutation in breast cancers from Austrian women. J Clin Invest (1995) 0.95
Acetylcholine receptors in small cell carcinomas. J Neurochem (1985) 0.95
Left atrial appendage flow velocities in subjects with normal left ventricular function. Am J Cardiol (2000) 0.94
Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J Virol (1993) 0.94
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. Br J Cancer (1996) 0.94
Identification of two novel regulatory elements within the 5'-untranslated region of the human A gamma-globin gene. J Biol Chem (1995) 0.94
Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes (Lond) (2013) 0.94
Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.92
SPTLC1 and RAB7 mutation analysis in dominantly inherited and idiopathic sensory neuropathies. J Neurol Neurosurg Psychiatry (2005) 0.92
Association of atrial fibrillation and aortic atherosclerosis: a population-based study. Mayo Clin Proc (2001) 0.89
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant (2003) 0.89
IV immunoglobulin does not reverse established weakness in MS. Neurology (2000) 0.88
A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. Int J Cancer (2000) 0.88
Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther (2003) 0.88
Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis. Bone Marrow Transplant (2004) 0.87